Cited by 370Protease and Inhibitor MechanismsNeutrophil, Myeloperoxidase and Oxidative MechanismsCoagulation, Bradykinin, Polyphosphates, and Angioedema

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

ONO-5046, a novel inhibitor of human neutrophil elastase

Kawabata, Kazuhito, Suzuki, Mayumi, Sugitani, Masafumi, Imaki, Katsuhiro, Toda, Masaaki, Miyamoto, Tsumoru·1991·Biochemical and Biophysical Research Communications

DOI 10.1016/0006-291x(91)91862-7

Open this paper in CoChat — free account

Abstract

ONO-5046, N-[2-[4-(2,2-Dimethylpropionyloxy)phenylsulfonylamino] aminoacetic acid, competitively inhibited human neutrophil elastase (IC50 = 0.044 microM, Ki = 0.2 microM). It also inhibited leukocyte elastase obtained from rabbit, rat, hamster and mouse. However, ONO-5046 did not inhibit trypsin, thrombin, plasmin, plasma kallikrein, pancreas kallikrein, chymotrypsin and cathepsin G even at 100 microM. In in vivo studies, ONO-5046 suppressed lung hemorrhage in hamster (ID50 = 82 micrograms/kg) by intratracheal administration and increase of skin capillary permeability in guinea pig (ID50 = 9.6 mg/kg) by intravenous administration, both of which were induced by human neutrophil elastase.

Integrity signals

Registry

Crossref · 10.1016/0006-291x(91)91862-7

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Elastolytic Activity in Pulmonary Lavage Fluid from Patients with Adult Respiratory-Distress Syndrome
Lee, C. T., Fein, A. M., Lippmann, M. L., Holtzman, H., Kimbel, P., & Weinbaum, G. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101223040402 · Cited by 516
Proteolysis by Neutrophils
Campbell, E. J., Senior, R. M., McDonald, J. A., Cox, D. L., Greco, J. M., & Landis, J. A. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110681 · Cited by 243
Purification and specificity of pancreatic elastase
Naughton, M. A., & Sanger, F. (1961) · Biochemical Journal · doi:10.1042/bj0780156 · Cited by 206
Physiology and Pathophysiology of Neutral Proteinases of Human Granulocytes
HAVEMANN, K., & Gramse, M. (1984) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-9355-3_1 · Cited by 132
Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: effects of substrate opsonization.
Campbell, E. J., & Campbell, M. A. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.106.3.667 · Cited by 125
Elastase-mediated fibrinogenolysis by chemoattractant-stimulated neutrophils occurs in the presence of physiologic concentrations of antiproteinases.
Weitz, J. I., Huang, A. J. Y., Landman, S. L., Nicholson, S., & Silverstein, S. C. (1987) · The Journal of Experimental Medicine · doi:10.1084/jem.166.6.1836 · Cited by 120
Neutrophil-mediated solubilization of the subendothelial matrix: oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes.
Weiss, S. J., Curnutte, J. T., & REGIANI, S. R. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.2.636 · Cited by 112
Rheumatoid arthritis
Weissmann, G., & Korchak, H. M. (1984) · Inflammation · doi:10.1007/bf00915708 · Cited by 78
A new class of inhibitors of human leucocyte elastase
Hassall, C. H., Johnson, W. H., Kennedy, A. J., & Roberts, N. A. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80776-6 · Cited by 37
A novel method of isolation and some characteristic properties of human pancreatic elastases
Fujimoto, K.-I., Ogawa, M., Saito, N., Kōsaki, G., Minamiura, N., & Yamamoto, T. (1980) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(80)90300-9 · Cited by 21

Show all 13 references

Research works printed but not linked: 7

Carp, 1982, 79, 2041
Jochum, 1986, Behring Inst. Mitt, 79, 121
Krell, 1988, FASEB Journal, 2, A346
Trainor, 1987, TIPS, 8, 303
Levine, 1976, Am. Rev. Respir. Dis, 113, 25
Matsuoka, 1989, Japan J. Pharmacol, 51, 455, 10.1254/jjp.51.455 · DOI
Soskel, 1986, Am. Rev. Respir. Dis, 133, 635

Sorted by citations

Items 301–370 of 370

Effects of Neutrophil Elastase Inhibitor on Progression of Acute Lung Injury After Liver Transplantation
Kaido, T., & Üemoto, S. (2010) · Transplantation · doi:10.1097/tp.0b013e3181e49bf2 · Cited by 4
Polysulfone Membranes Doped with Human Neutrophil Elastase Inhibitors: Assessment of Bioactivity and Biocompatibility
Rocha, S., Félix, R., Valente, M. J., Bento‐Silva, A., Rebelo, R., Amorim, C. G., Araújo, A. N., Moreira, R., Santos‐Silva, A., & Montenegro, M. C. B. S. M. (2023) · Membranes · doi:10.3390/membranes13010089 · Cited by 3
A Randomised, Placebo-Controlled, Dose-Finding Study Of AZD9668, An Oral Inhibitor of Neutrophil Elastase, in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium
Vogelmeier, C. F., Aquino, T. O., O’Brien, C. D., Perrett, J., & Gunawardena, K. A. (2012) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.641803 · Cited by 3
Pancreas Preservation with a Neutrophil Elastase Inhibitor, Alvelestat, Contributes to Improvement of Porcine Islet Isolation and Transplantation
Otsuka, R., Miyagi-Shiohira, C., Kuwae, K., Nishime, K., Tamaki, Y., Yonaha, T., Sakai-Yonaha, M., Yamasaki, I., Shinzato, M., Saitoh, I., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154290 · Cited by 2
Studies on the Metabolic Fate of Neutrophil Elastase Inhibitor ONO-5046Na. (5): Plasma Concentration-Profile after Intravenous Bolus Administration or Intravenous Infusion to Rats and Dogs.
FUJIMOTO, H., Shintani, T., Takamoto, M., YAMAMOTO, R., & HIRAKU, S. (1998) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.13.28 · Cited by 3
Discrimination of Methionine Sulfoxide and Sulfone by Human Neutrophil Elastase
Leahy, D., Grant, C., Jackson, A., Duff, A., Tardiota, N., Van Haeften, J., Chen, X., Peake, J. M., Kruppa, M. D., Smith, E. T., et al. (2021) · Molecules · doi:10.3390/molecules26175344 · Cited by 2
“This notion is consistent with the observation of sulfone moieties in inhibitor drugs targeting HNE, including Sivelestat [22] and the Bayer inhibitor, BAY 85-8501 [23].”
BackgroundResult
The effectiveness of selective neutrophil elastase inhibitors (sivelestat) in acute lung injury or acute respiratory distress syndrome: A systematic review and meta-analysis of randomized controlled trials
Charoensappakit, A., Sae‐khow, K., Vutthikraivit, N., Maneesow, P., Doi, K., Pachinburavan, M., & Leelahavanichkul, A. (2026) · Journal of the Intensive Care Society · doi:10.1177/17511437261425058 · Cited by 2
Studies on Elastase and Elastase Inhibitor from Aspergillus flavus
Nikai, T. (2021) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.20-00193 · Cited by 2
The multiple hit model of infantile and epileptic spasms: The 2025 update
Galanopoulou, A. S., Mowrey, W. B., Liu, W., Katsarou, A., Li, Q., Shandra, O. O., & Moshé, S. L. (2025) · Epilepsia Open · doi:10.1002/epi4.70158 · Cited by 2
Utilization of computational methods for the identification of new natural inhibitors of human neutrophil elastase in inflammation therapy
Alzain, A. A., Elbadwi, F. A., Al-Karmalawy, A. A., Elhag, R. I., Osman, W., & Mothana, R. A. (2023) · Open Chemistry · doi:10.1515/chem-2023-0161 · Cited by 2
Hepatic Clearance of ONO-5046, a Novel Neutrophil Elastase Inhibitor, in Rats and in the Rat Perfused Liver
Murakami, T., Sato, M., Higashikawa, F., Okochi, A., Higashi, Y., Yata, N., & Takano, M. (1998) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1998.tb06883.x · Cited by 2
Human Neutrophil Elastase and the Protein-Storm Axis: Reversible Synthetic Inhibitors in Inflammatory Disease
Viglio, S., Grignano, M. A., Gregorini, M., Rampino, T., Pietrocola, G., & Iadarola, P. (2026) · Molecules · doi:10.3390/molecules31091441 · Cited by 1
Nuevas perspectivas terapéuticas farmacológicas en el manejo de la EPOC
Cosío, B. G., & Sánchez, B. N. (2007) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(07)74007-3 · Cited by 1
CURCUMIN, GARCINOL AND DIETARY N-3 FATTY ACIDS, LOWER THE RELEASE OF LYSOSOMAL ENZYMES IN RAT PERITONEAL MACROPHAGES.
Pasha, P. F., Ramachandran, K., & Ramachandran, H. D. (2015) · ePrints@Bangalore University (Bangalore University) · Cited by 1
Studies on the Metabolic Fate of Neutrophil Elastase Inhibitor ONO-5046Na (1): Plasma Concentration-profile, Distribution and Excretion after Single Intravenous Administration to Rats.
FUJIMOTO, H., Imawaka, H., Komaba, J., YAMAMOTO, R., & HIRAKU, S. (1997) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.12.551 · Cited by 1
Studies on the Metabolic Fate of Neutrophil Elastase Inhibitor ONO-5046Na(3): Metabolism and Binding to Serum Protein in Various Animal Species.
FUJIMOTO, H., Imawaka, H., Nakade, S., YAMAMOTO, R., & HIRAKU, S. (1997) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.12.576 · Cited by 1
Studies on the Metabolic Fate of Neutrophil Elastase Inhibitor ONO-5046Na(4): Feto-Placental Transfer and Excretion into Milk.
FUJIMOTO, H., Komaba, J., YAMAMOTO, R., & HIRAKU, S. (1997) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.12.589 · Cited by 1
Studies on the Metabolic Fate of Neutrophil Elastase Inhibitor ONO-5046Na (2): Plasma concentration-profile, Distribusion and Excretion after Repeated Intravenous Bolus Administration to Rats and Effects on Metabolizing Enzyme Activities.
FUJIMOTO, H., Imawaka, H., Komaba, J., YAMAMOTO, R., & HIRAKU, S. (1997) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.12.566 · Cited by 1
TOXICITY STUDY OF SODIUM N-[2-[4-(2, 2-DIMETHYLPROPIONYLOXY)PHENYLSULFONYLAMINO]BENZOYL]AMINOACETATE TETRAHYDRATE(ONO-5046·Na)(5)6-MONTH REPEATED DOSE INTRAVENOUS TOXICITY STUDY IN DOGS WITH 1-MONTH RECOVERY TEST
OKAMOTO, M., Makoto, I. D. E., SUZUKI, H., ISHII, T., TAMURA, K., Numata, H., KATSUMATA, T., & Fujita, T. (1998) · The Journal of Toxicological Sciences · doi:10.2131/jts.23.supplementiii_483 · Cited by 1
Robustaflavone as a novel scaffold for inhibitors of native and auto-proteolysed human neutrophil elastase
Singh, V., Kumar, Y., & Bhatnagar, S. (2024) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2024.2394498 · Cited by 1
Neutrophil elastase in pressure ulcer fluid degrades fibronectin in the exudates
Ai, S., Kuzuya, M., & Iguchi, A. (2004) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2004.00243.x · Cited by 1
Effect of YM-47141, A New Inhibitor Produced byFlexzbactor SR Q17897, Onelastase
Teramura, K., Yasumuro, K., & Abe, K. (1996) · Journal of enzyme inhibition · doi:10.3109/14756369609038220 · Cited by 1
Avancées thérapeutiques dans les bronchopneumopathies chroniques obstructives
Parienté, R., & Aubier, M. (2004) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)33842-7 · Cited by 1
Translational Control in Bone Marrow Failure
Horwitz, M. S. (2014) · Defense Technical Information Center (DTIC) · doi:10.21236/ada605027
The role of O2- and neutrophil elastase, and their interaction in the pathogenesis of acute lung injury.
Kinoshita, M., Mochizuki, H., Ono, S., Aosasa, S., & Tamakuma, S. (1996) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.3893/jjaam.7.325
Mechanisms of tolerance and Th2 cell activation in asthma
Baghai-Ravary, R. (2004) · Thorax · doi:10.1136/thx.2004.la0116
Effect of the Neutrophil Elastase Inhibitor on Acute Lung Injury after Pulmonary Resection for Lung Cancer: A Preliminary Study
Park, S. Y., Park, S., Jeon, K., Lim, S. Y., Park, M. R., Kim, S., Song, J. U., Kim, J. G., Kwon, O. J., & Suh, G. Y. (2009) · The Korean Journal of Critical Care Medicine · doi:10.4266/kjccm.2009.24.3.124
Characterization of blood-brain barrier disruption in a focal model of neuromyelitis optica
Winkler, A. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5374
Effect of Sivelestat Sodium Hydrate in Three Patients with Septic ARDS
Kitamura, M., Endo, S., Sato, N., Yamada, Y., Makabe, H., Abe, H., Imai, S., Shioya, N., Takahashi, G., Mori, K., et al. (2003)
lung injury after intestinal ischemia-reperfusion Effects of neutrophil elastase inhibitor (ONO-5046) on
Yoshida, M., Takayama, M., Ishibashi, M., Ishii, H., & Kuraki, T. (2015)
Successful treatment of severe acute pancreatitis-related ARDS with systemic infusion of neutrophil elastase inhibitor (sivelestat sodium)
Kawabe, K., Ito, T., Arita, Y., Inoue, N., & Nawata, H. (2005) · Suizo · doi:10.2958/suizo.20.477
REPRODUCTIVE AND DEVELOPMENTAL TOXICITY STUDY OF SODIUM N-[2-[4-(2, 2-DIMETHYLPROPIONYLOXY)PHENYLSULFONYLAMINO]BENZOYL]AMINOACETATE TETRAHYDRATE(ONO-5046·Na)(1)FERTILITY STUDY IN RATS
CHIHARA, N., yoshiya, A. Z. E., NISHIMURA, T., SHIRAKAWA, R., SAKAMOTO, T., NAKAGAWA, Y., SUGAI, S., OZEKI, Y., KITAGAWA, T., SHINOMIYA, K., et al. (1998) · The Journal of Toxicological Sciences · doi:10.2131/jts.23.supplementiii_503
SODIUM N-[2-[4-(2, 2-DIMETHYLPROPIONYLOXY)PHENYLSULFONYLAMINO]BENZOYL]AMINOACETATE TETRAHYDRATE(ONO-5046·Na)(2)4-WEEK REPEATED DOSE INTRAVENOUS TOXICITY STUDY IN RATS WITH 4-WEEK RECOVERY TEST
YANAGI, H., YAMAGUCHI, K., Shimizu, K., Shichino, Y., NISHIYAMA, K., Mori, H., SHINOMIYA, K., Ueda, H. T., Suzuki, Y., Oida, H., et al. (1998) · The Journal of Toxicological Sciences · doi:10.2131/jts.23.supplementiii_415
TOXICITY STUDY OF SODIUM N-[2-[4-(2, 2-DIMETHYLPROPIONYLOXY)PHENYLSULFONYLAMINO]BENZOYL] AMINOACETATE TETRAHYDRATE(ONO-5046·Na)(1)SINGLE-DOSE INTRAVENOUS TOXICITY STUDIES IN RATS AND DOGS
YANAGI, H., Yamaguchi, K., Shimizu, K., Shichino, Y., NISHIYAMA, K., Mori, H., SHINOMIYA, K., Hiroaki, U. E. D. A., Suzuki, Y., YONEZAWA, H., et al. (1998) · The Journal of Toxicological Sciences · doi:10.2131/jts.23.supplementiii_409
REPRODUCTIVE AND DEVELOPMENTAL TOXICITY STUDY OF SODIUM N-[2-[4-(2, 2-DIMETHYLPROPIONYLOXY)PHENYLSULFONYLAMINO]BENZOYL]AMINOACETATE TETRAHYDRATE(ONO-5046·Na)(2)STUDY FOR EFFECTS ON PRE-AND POSTNATAL DEVELOPMENT IN RATS, INCLUDING MATERNAL FUNCTION
Nishimura, T., CHIHARA, N., SUGAI, S., SAKAMOTO, T., SHIRAKAWA, R., NAKAGAWA, Y., IKEDA, Y., Aze, Y., OZEKI, Y., SHINOMIYA, K., et al. (1998) · The Journal of Toxicological Sciences · doi:10.2131/jts.23.supplementiii_515
Rikkunsi-to Prevents Indomethacin induced Gastric Mucosal Injury by Inhibiting Activation of Leukocytes.
Murakami, K. (1997) · 日本東洋醫學雜誌 · doi:10.3937/kampomed.48.1
Antioxidants and Protease Inhibitors
Matera, M. G., & Cazzola, M. (2003) · Lung biology in health and disease · doi:10.1201/9780203913406.ch16
ROLE OF NEUTROPHIL ELASTASE AND PROTEINASE-ACTIVATED RECEPTOR-2 IN THE JOINT INFLAMMATION AND PAIN ASSOCIATED WITH EXPERIMENTAL ARTHRITIS
Muley, M. M. (2018) · DalSpace (Dalhousie University)
Sivelestat
Yoshida, K. (2008) · Springer eBooks · doi:10.1007/978-3-540-47648-1_5332
Sivelestat
Yoshida, K. (2015) · Springer eBooks · doi:10.1007/978-3-642-27841-9_5332-2
Sivelestat
Yoshida, K. (2015) · Springer eBooks · doi:10.1007/978-3-662-46875-3_5332
Sivelestat
Yoshida, K. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_5332
The Structure-property Relationships of Clinically Approved Protease Inhibitors
Choi, K. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230409232655 · Cited by 1
Effect of Neutrophil Elastase Inhibitor (Sivelestat Sodium) on Oxygenation in Patients with Sepsis Induced Acute Respiratory Distress SyndromePreprint
Wu, T., Wang, T., Jiang, J., Tang, Y., Zhang, L., Jiang, Z., Liu, F., Kong, G., Zhou, T., Liu, R., et al. (2024) · medRxiv · doi:10.1101/2024.05.30.24308242
Expression and purification of human neutrophil proteinase 3 from insect cells and characterization of ligand binding
Khorsand, F., Haug, B. E., Kursula, I., Reuter, N., & Brenk, R. (2024) · PLoS ONE · doi:10.1371/journal.pone.0294827
Sivelestat Sodium in the Treatment of Patients with Acute Respiratory Distress Syndrome Combined with Systemic Inflammatory Response SyndromePreprint
He, H., & Huang, X. (2024) · medRxiv · doi:10.1101/2024.07.28.24311151
Effect of Neutrophil Elastase Inhibitor (Sivelestat Sodium) on Oxygenation in Patients with Sepsis Induced Acute Respiratory Distress SyndromePreprint
Wu, T., Wang, T., Jiang, J., Tang, Y., Zhang, L., Jiang, Z., Liu, F., Kong, G., Zhou, T., Liu, R., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4918271/v1
Enzymatic, structural, and biophysical characterization of a single‐domain antibody (VHH) selectively and tightly inhibiting neutrophil elastase and exhibiting favorable developability properties
Redeghieri, P., Moray, J., Kerff, F., Gohy, S. T., Leal, T., Muyldermans, S., Rita Vanbever, A., Morales-Yánez, F., & Dumoulin, M. (2024) · Protein Science · doi:10.1002/pro.5227
Elastase mediated white matter damage in cerebral small vessel disease: Microglia - neutrophils pas de deuxPreprint
Dong, C.-Y., Chen, W., Li, Q., Fan, J., Lan, T., Dong, W., Sun, L., Wang, Y., Shi, M., Huang, Y., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.23.630204
Efficacy of Thymosin Alpha 1 Combined with Sivelestat and Ambroxol in Elderly Sepsis-Associated ARDS: A Randomized TrialPreprint
Yun, P., Han, L., Xie, Z., Yang, Y., Weng, X., Yang, L., Wu, Y., Mo, L., & Cui, Y. (2025) · Research Square · doi:10.21203/rs.3.rs-7666496/v1
New drugs for COPD based on advances in pathophysiology
Hansel, T. T., Tennant, R. C., Erin, E. M., Tan, A. J., & Barnes, P. J. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7939-2_12
Nouvelle approche du traitement de l’emphysème ;Synthèse et activité biologique d’inhibiteurs de l’élastase neutrophile humaine.
Huynh, T. N. T. (2014) · doi:10.70675/6dd187b1z63a9z4bbaza087zc802ababf919
The Differential Redox Resilience of Alvelestat and Sivelestat: A Mechanistic Hypothesis for Inhibitor Performance Under Oxidative Stress
D’Amato, M., Linciano, P., Chiarelli, L. R., Pietrocola, G., Iadarola, P., Collina, S., Grignano, M. A., Gregorini, M., Rampino, T., & Viglio, S. (2026) · Molecules · doi:10.3390/molecules31091454
Ferritin Nanoparticle-Mediated Sustained Delivery of Sivelestat with Poor Water Affinity Attenuates Acute Lung Injury via Dual Inhibition of NETs and Pyroptosis
Wang, H., Feng, T., Geng, L., Zhou, X., Luo, J., & Jiang, K. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c08679
Development of atropisomeric 5 N -sulfonyl-1,5-benzodiazepin-2-ones with high inhibitory activity against neutrophil elastase
Tabata, H., Miyata, Y., Kusakabe, Y., Takahashi, H., Natsugari, H., & Oshitari, T. (2026) · RSC Medicinal Chemistry · doi:10.1039/d6md00430j
A dendritic cell autophagy–neutrophil axis limits intratumoral STING immunotherapy
Loverre, A., Jneid, B., Delisle, F., Genest, M., Alkhoury, C., Antoniadou, K., & Manel, N. (2026) · Science Immunology · doi:10.1126/sciimmunol.adw6399
An Automated Scalable Chemoproteomics Workflow that Recovers Known Serine Hydrolase Target Profiles of Clinically Used Drugs
Brake, F. H. G. T., Gagestein, B., van der Stelt, M., & Janssen, A. P. A. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.6c00557
BindingDB Entry 3476: Development of a highly water-soluble peptide-based human neutrophil elastase inhibitor; AE-3763 for treatment of acute organ injury.
BindingDB (2009) · UC San Diego · doi:10.7270/q22z13w5
BindingDB Entry 50011315: Lung Protection by Cathepsin C Inhibition: A New Hope for COVID-19 and ARDS?
BindingDB (2022) · UC San Diego · doi:10.7270/q2sx6ht9
BindingDB Entry 50033670: Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase.
BindingDB (2012) · UC San Diego · doi:10.7270/q2jd4x5n
BindingDB Entry 50007683: Ahp-Cyclodepsipeptide Inhibitors of Elastase: Lyngbyastatin 7 Stability, Scalable Synthesis, and Focused Library Analysis.
BindingDB (2021) · UC San Diego · doi:10.7270/q28p63w5
BindingDB Entry 50044827: Reversible ketomethylene-based inhibitors of human neutrophil proteinase 3.
BindingDB (2016) · UC San Diego · doi:10.7270/q2vq349f
BindingDB Entry 50036895: Protease inhibitors: current status and future prospects.
BindingDB (2012) · UC San Diego · doi:10.7270/q2jd4xh4
BindingDB Entry 50043246: Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase.
BindingDB (2014) · UC San Diego · doi:10.7270/q2mc91fn
BindingDB Entry 50007248: Anionic- and lipophilic-mediated surface binding inhibitors of human leukocyte elastase.
BindingDB (2009) · UC San Diego · doi:10.7270/q26d5s4t
BindingDB Entry 50046586: Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases: Into clinical testing with pre-adaptive pharmacophores.
BindingDB (2016) · UC San Diego · doi:10.7270/q29z96px
BindingDB Entry 50040669: Synthesis and evaluation of silanediols as highly selective uncompetitive inhibitors of human neutrophil elastase.
BindingDB (2013) · UC San Diego · doi:10.7270/q2b27wd6
BindingDB Entry 50022876: Sensitive quantification of fibroblast activation protein and high-throughput screening for inhibition by FDA-approved compounds.
BindingDB (2026) · UC San Diego · doi:10.7270/q26978dx
BindingDB Entry 50018635: Covalent Small Molecule Immunomodulators Targeting the Protease Active Site.
BindingDB (2024) · UC San Diego · doi:10.7270/q2t72nnm
Novel Anti-inflammatory Therapies
Barnes, P. J., & Page, C. P. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-09264-4_13

Authors: Kawabata, K., Suzuki, M., Sugitani, M., Imaki, K., Toda, M., & Miyamoto, T.
Affiliations: Ono Pharmaceutical (Japan) (JP)
ORCID: Suzuki, Mayumi
Venue: Biochemical and Biophysical Research Communications
Publisher: Elsevier BV
Published: 1991-06
Volume: 177
Issue: 2
Pages: 814-820
ISSN: 0006-291X (ISSN-L)
DOI: 10.1016/0006-291x(91)91862-7
OpenAlex: W2039697569
Cited by: 359
References: 13
Citations by year: 2026: 8 · 2025: 6 · 2024: 11 · 2023: 10 · 2022: 10 · 2021: 9 · 2020: 7 · 2019: 9 · 2018: 7 · 2017: 8 · 2016: 8 · 2015: 18 · 2014: 8 · 2013: 11 · 2012: 12
FWCI: 2.09
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biochemical and Biophysical Research Communications (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
Keywords: ONO-5046, human neutrophil elastase, leukocyte elastase, elastase inhibitors, competitive inhibition, serine protease inhibition, pulmonary hemorrhage
MeSH terms: Animals, Binding, Competitive, Capillary Permeability, Glycine, Guinea Pigs, Cricetinae, Hemorrhage, Humans, Lung Diseases, Male, Mesocricetus, Neutrophils, Pancreatic Elastase, Rabbits, Skin Diseases, Sulfonamides, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

ONO-5046, a novel inhibitor of human neutrophil elastase

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks